Skip to main content
SpringerLink
Log in

Comprehensive Wound Care for Malignant Wounds

  • Chapter
  • First Online:
Local Wound Care for Dermatologists

Part of the book series: Updates in Clinical Dermatology ((UCD))

Abstract

Malignant wounds (MW) are a rare complication of advanced cancer in which tumor cells infiltrate and erode through the skin. MW can be extremely distressing to patients given their high burden of symptoms, which include malodor, exudate, bleeding, pain, shame, low self-esteem, and social isolation. Treatment goals focus on improving patients’ quality of life. Management of MW requires highly individualized, multidisciplinary care based on the symptom burden, psychosocial impact, and personal values of the patient. This chapter provides an overview of the major symptoms of MW and comprehensively reviews management discussed in the literature. Evidence regarding palliative cancer-directed therapies for MWs is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander S. Malignant fungating wounds: epidemiology, aetiology, presentation and assessment. J Wound Care. 2009;18(7):273–4, 276–8, 280.

    Article  CAS  PubMed  Google Scholar 

  2. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29(2 Pt 1):228–36.

    Article  CAS  PubMed  Google Scholar 

  3. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J Am Acad Dermatol. 1990;22(1):19–26.

    Article  CAS  PubMed  Google Scholar 

  4. Maida V, Corbo M, Dolzhykov M, Ennis M, Irani S, Trozzolo L. Wounds in advanced illness: a prevalence and incidence study based on a prospective case series. Int Wound J. 2008;5(2):305–14.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs. 2009;13(4):295–8.

    Article  PubMed  Google Scholar 

  6. Maida V, Ennis M, Kuziemsky C, Trozzolo L. Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manag. 2009;37(2):206–11.

    Article  Google Scholar 

  7. Marcoval J, Moreno A, Peyri J. Cutaneous infiltration by cancer. J Am Acad Dermatol. 2007;57(4):577–80.

    Article  PubMed  Google Scholar 

  8. Naylor W. Malignant wounds: aetiology and principles of management. Nurs Stand. 2002;16(52):45–53; quiz e54, 56.

    Article  PubMed  Google Scholar 

  9. McDonald A, Lesage P. Palliative management of pressure ulcers and malignant wounds in patients with advanced illness. J Palliat Med. 2006;9(2):285–95.

    Article  PubMed  Google Scholar 

  10. Tilley C, Lipson J, Ramos M. Palliative wound care for malignant fungating wounds: holistic considerations at end-of-life. Nurs Clin North Am. 2016;51(3):513–31.

    Article  PubMed  Google Scholar 

  11. Beh SY, Leow LC. Fungating breast cancer and other malignant wounds: epidemiology, assessment and management. Expert Rev Qual Life Cancer Care. 2016;1(2):137–44.

    Article  Google Scholar 

  12. Grocott P, Cowley S. The palliative management of fungating malignant wounds--generalising from multiple-case study data using a system of reasoning. Int J Nurs Stud. 2001;38(5):533–45.

    Article  CAS  PubMed  Google Scholar 

  13. Alexander S. Malignant fungating wounds: key symptoms and psychosocial issues. J Wound Care. 2009;18(8):325–9.

    Article  CAS  PubMed  Google Scholar 

  14. Lo SF, Hayter M, Hu WY, Tai CY, Hsu MY, Li YF. Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs. 2012;68(6):1312–21.

    Article  PubMed  Google Scholar 

  15. Gibson S, Green J. Review of patients’ experiences with fungating wounds and associated quality of life. J Wound Care. 2013;22(5):265–6, 268, 270–2, passim.

    Article  CAS  PubMed  Google Scholar 

  16. Lo SF, Hu WY, Hayter M, Chang SC, Hsu MY, Wu LY. Experiences of living with a malignant fungating wound: a qualitative study. J Clin Nurs. 2008;17(20):2699–708.

    Article  PubMed  Google Scholar 

  17. Dolbeault S, Flahault C, Baffie A, Fromantin I. Psychological profile of patients with neglected malignant wounds: a qualitative exploratory study. J Wound Care. 2010;19(12):513–4. 516, 518–21.

    Google Scholar 

  18. Lazelle-Ali C. Psychological and physical care of malodorous fungating wounds. Br J Nurs. 2007;16(15):S16–24.

    Article  PubMed  Google Scholar 

  19. Merz T, Klein C, Uebach B, Kern M, Ostgathe C, Bukki J. Fungating wounds – multidimensional challenge in palliative care. Breast Care (Basel). 2011;6(1):21–4.

    Article  Google Scholar 

  20. Alexander SJ. An intense and unforgettable experience: the lived experience of malignant wounds from the perspectives of patients, caregivers and nurses. Int Wound J. 2010;7(6):456–65.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Browne N, Grocott P, Cowley S, Cameron J, Dealey C, Keogh A, Lovatt A, Vowden K, Vowden P. Woundcare Research for Appropriate Products (WRAP): validation of the TELER method involving users. Int J Nurs Stud. 2004;41(5):559–71.

    Article  PubMed  Google Scholar 

  22. Grocott P. Developing a tool for researching fungating wounds. World Wide Wounds. 2001;1–17.

    Google Scholar 

  23. Schulz V, Kozell K, Biondo PD, Stiles C, Martins L, Tonkin K, Hagen NA. The malignant wound assessment tool: a validation study using a Delphi approach. Palliat Med. 2009;23(3):266–73.

    Article  CAS  PubMed  Google Scholar 

  24. Naylor W. Part 2: Symptom self-assessment in the management of fungating wounds. World Wide Wounds. 2002; www.worldwidewounds.com/2002/july/Naylor-Part2/Wound-Assessment-Tool.html

  25. Alexander S. Malignant fungating wounds: managing malodour and exudate. J Wound Care. 2009;18(9):374–82.

    Article  CAS  PubMed  Google Scholar 

  26. Chrisman CA. Care of chronic wounds in palliative care and end-of-life patients. Int Wound J. 2010;7(4):214–35.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Naylor W. Part 1: Symptom control in the management of fungating wounds. World Wide Wounds. 2002.

    Google Scholar 

  28. Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K. Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds. Biosci Biotechnol Biochem. 2009;73(9):2117–20.

    Article  CAS  PubMed  Google Scholar 

  29. O’Brien C. Malignant wounds: managing odour. Can Fam Physician. 2012;58(3):272–4; e141–3.

    PubMed  PubMed Central  Google Scholar 

  30. Young CV. The effects of malodorous fungating malignant wounds on body image and quality of life. J Wound Care. 2005;14(8):359–62.

    Article  CAS  PubMed  Google Scholar 

  31. Woo KY, Sibbald RG. Local wound care for malignant and palliative wounds. Adv Skin Wound Care. 2010;23(9):417–28; quiz 429–30.

    Article  PubMed  Google Scholar 

  32. Fromantin I, Seyer D, Watson S, Rollot F, Elard J, Escande MC, De Rycke Y, Kriegel I, Larreta GV. Bacterial floras and biofilms of malignant wounds associated with breast cancers. J Clin Microbiol. 2013;51(10):3368–73.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Tandler S, Stephen-Haynes J. Fungating wounds: management and treatment options. Br J Nurs. 2017;26(12 Suppl):S6–S14.

    Article  PubMed  Google Scholar 

  34. Dunford CE. Treatment of a wound infection in a patient with mantle cell lymphoma. Br J Nurs. 2001;10(16):1058, 1060, 1062, 1064–5.

    Article  CAS  PubMed  Google Scholar 

  35. Sealby N. The use of maggot therapy in the treatment of a malignant foot wound. Br J Community Nurs. 2004;9(3):S16–9.

    Article  PubMed  Google Scholar 

  36. Lin Y, Amin M, Donnelly AFW, Amar S. Maggot debridement therapy of a leg wound from Kaposi’s sarcoma: a case report. J Glob Oncol. 2015;1(2):92–8.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Jones M, Thomas S. A case history describing the use of sterile larvae (maggots) in a malignant wound. World Wide Wounds. 1998; February.

    Google Scholar 

  38. Kalemikerakis J, Vardaki Z, Fouka G, Vlachou E, Gkovina U, Kosma E, Dionyssopoulos A. Comparison of foam dressings with silver versus foam dressings without silver in the care of malodorous malignant fungating wounds. J BUON. 2012;17(3):560–4.

    CAS  PubMed  Google Scholar 

  39. Lund-Nielsen B, Adamsen L, Kolmos HJ, Rørth M, Tolver A, Gottrup F. The effect of honey-coated bandages compared with silver-coated bandages on treatment of malignant wounds-a randomized study. Wound Repair Regen. 2011;19(6):664–70.

    Article  PubMed  Google Scholar 

  40. da Costa Santos CM, de Mattos Pimenta CA, Nobre MRC. A systematic review of topical treatments to control the odor of malignant fungating wounds. J Pain Symptom Manag. 2010;39(6):1065–76.

    Article  CAS  Google Scholar 

  41. Bower M, Stein R, Evans TR, Hedley A, Pert P, Coombes RC. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. Eur J Cancer. 1992;28A(4–5):888–9.

    Article  CAS  PubMed  Google Scholar 

  42. Finlay IG, Bowszyc J, Ramlau C, Gwiezdzinski Z. The effect of topical 0.75% metronidazole gel on malodorous cutaneous ulcers. J Pain Symptom Manag. 1996;11(3):158–62.

    Article  CAS  Google Scholar 

  43. Kalinski C, Schnepf M, Laboy D, Hernandez L, Nusbaum J, McGrinder B, Comfort C, Alvarez O. Effectiveness of a topical formulation containing metronidazole for wound odor and exudate control. Wounds. 2005;17(4):84–90.

    Google Scholar 

  44. Kuge S, Tokuda Y, Ohta M, Okumura A, Kubota M, Ninomiya S, Sawamura S, Makuuchi H, Tajima T, Mitomi T. Use of metronidazole gel to control malodor in advanced and recurrent breast cancer. Jpn J Clin Oncol. 1996;26(4):207–10.

    Article  CAS  PubMed  Google Scholar 

  45. Watanabe K, Shimo A, Tsugawa K, Tokuda Y, Yamauchi H, Miyai E, Takemura K, Ikoma A, Nakamura S. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013). Support Care Cancer. 2016;24(6):2583–90.

    Article  PubMed  Google Scholar 

  46. Ashford R, Plant G, Maher J, Teare L. Double-blind trial of metronidazole in malodorous ulcerating tumours. Lancet. 1984;1(8388):1232–3.

    Article  CAS  PubMed  Google Scholar 

  47. George R, Prasoona TS, Kandasamy R, Cherian R, Celine T, Jeba J, Murali S, Mathew D. Improving malodour management in advanced cancer: a 10-year retrospective study of topical, oral and maintenance metronidazole. BMJ Support Palliat Care. 2017;7(3):286–91.

    PubMed  Google Scholar 

  48. Alexander S. Malignant fungating wounds: managing pain, bleeding and psychosocial issues. J Wound Care. 2009;18(10):418–25.

    Article  CAS  PubMed  Google Scholar 

  49. Tamai N, Mugita Y, Ikeda M, Sanada H. The relationship between malignant wound status and pain in breast cancer patients. Eur J Oncol Nurs. 2016;24:8–12.

    Article  PubMed  Google Scholar 

  50. Gallagher R. Management of painful wounds in advanced disease. Can Fam Physician. 2010;56(9):883–5, e315–7

    PubMed  PubMed Central  Google Scholar 

  51. World Health Organization. Cancer pain relief: with a guide to opioid availability. 2nd ed. Geneva: World Health Organization; 1996. Available at: http://www.who.int/iris/handle/10665/37896.

  52. Chuang C, Fonger E, Roth R, Campbell M. Challenges with accruing a study of topical opioid for painful malignant wounds: lessons learned. J Palliat Med. 2016;19(6):586.

    Article  PubMed  Google Scholar 

  53. Finlayson K, Teleni L, McCarthy AL. Topical opioids and antimicrobials for the management of pain, infection, and infection-related odors in malignant wounds: a systematic review. Oncol Nurs Forum. 2017;44(5):626–32.

    Article  PubMed  Google Scholar 

  54. Smith MT, Wyse BD, Edwards SR, El-Tamimy M, Gaetano G, Gavin P. Topical application of a novel oxycodone gel formulation (tocopheryl phosphate mixture) in a rat model of peripheral inflammatory pain produces localized pain relief without significant systemic exposure. J Pharm Sci. 2015;104(7):2388–96.

    Article  CAS  PubMed  Google Scholar 

  55. LeBon B, Zeppetella G, Higginson IJ. Effectiveness of topical administration of opioids in palliative care: a systematic review. J Pain Symptom Manag. 2009;37(5):913–7.

    Article  Google Scholar 

  56. Maida V. Medical cannabis in the palliation of malignant wounds-a case report. J Pain Symptom Manag. 2017;53(1):e4–6.

    Article  Google Scholar 

  57. Lee JJ, Girouard SD, Carlberg VM, Mostaghimi A. Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse. BMJ Support Palliat Care. 2016;6(1):119–21.

    Article  PubMed  Google Scholar 

  58. Wiechert AC, Garrett LA, Lin G, Goodman A. Management of a skin metastasis in a patient with advanced ovarian cancer. Gynecol Oncol Case Rep. 2012;2(4):124–6.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Demling RH, De Santi L. Topical doxepin significantly decreases itching and erythema in the healed burn wound compared to oral antihistamines. J Burn Care Rehabil. 2002;23:S81.

    Article  Google Scholar 

  60. Demling RH, De Santi L. Topical doxepin significantly decreases itch and erythema in the chronically pruritic burn scar. Wounds. 2003;15:195–200.

    Google Scholar 

  61. Demierre MF, Taverna J. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006;55(3):543–4.

    Article  PubMed  Google Scholar 

  62. Ahuja RB, Gupta R, Gupta G, Shrivastava P. A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. Burns. 2011;37(2):203–7.

    Article  PubMed  Google Scholar 

  63. Song JS, Tawa M, Chau NG, Kupper TS, LeBoeuf NR. Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature. BMC Cancer. 2017;17(1):200.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Torres T, Fernandes I, Selores M, Alves R, Lima M. Aprepitant: evidence of its effectiveness in patients with refractory pruritus continues. J Am Acad Dermatol. 2012;66(1):e14–5.

    Article  PubMed  Google Scholar 

  65. Vincenzi B, Fratto ME, Santini D, Tonini G. Aprepitant against pruritus in patients with solid tumours. Support Care Cancer. 2010;18(9):1229–30.

    Article  PubMed  Google Scholar 

  66. Santini D, Vincenzi B, Guida FM, Imperatori M, Schiavon G, Venditti O, Frezza AM, Berti P, Tonini G. Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. Lancet Oncol. 2012;13(10):1020–4.

    Article  CAS  PubMed  Google Scholar 

  67. He A, Alhariri JM, Sweren RJ, Kwatra MM, Kwatra SG. Aprepitant for the treatment of chronic refractory pruritus. Biomed Res Int. 2017;2017:4790810.

    PubMed  PubMed Central  Google Scholar 

  68. Spratt DE, Gordon Spratt EA, Wu S, DeRosa A, Lee NY, Lacouture ME, Barker CA. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol. 2014;32(28):3144–55.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Kahler KC, Egberts F, Gutzmer R. Palliative treatment of skin metastases in dermato-oncology. J Dtsch Dermatol Ges. 2013;11(11):1041–5. quiz 1046

    Google Scholar 

  70. Lu YF, Lin YC, Chen KH, Shueng PW, Yeh HP, Hsieh CH. Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls. Onco Targets Ther. 2016;9:3025–30.

    PubMed  PubMed Central  Google Scholar 

  71. Lai YL, Chang HH, Huang MJ, Chang KH, Su WH, Chen HW, Chung CH, Wang WY, Lin LH, Chen YJ. Combined effect of topical arsenic trioxide and radiation therapy on skin-infiltrating lesions of breast cancer-a pilot study. Anti-Cancer Drugs. 2003;14(10):825–8.

    Article  CAS  PubMed  Google Scholar 

  72. Plesnicar S, Rudolf Z. Combined BCG and irradiation treatment of skin metastases originating from malignant melanoma. Cancer. 1982;50(6):1100–6.

    Article  CAS  PubMed  Google Scholar 

  73. Gaudy C, Richard MA, Folchetti G, Bonerandi JJ, Grob JJ. Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma. J Cutan Med Surg. 2006;10(3):115–21.

    Article  PubMed  Google Scholar 

  74. Byrne CM, Thompson JF, Johnston H, Hersey P, Quinn MJ, Michael Hughes T, McCarthy WH. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res. 2005;15(1):45–51.

    Article  CAS  PubMed  Google Scholar 

  75. Seyed Jafari SM, Jabbary Lak F, Gazdhar A, Shafighi M, Borradori L, Hunger RE. Application of electrochemotherapy in the management of primary and metastatic cutaneous malignant tumours: a systematic review and meta-analysis. Eur J Dermatol. 2018;28(3):287–313.

    CAS  PubMed  Google Scholar 

  76. Morrison SA, Hill SL, Rogers GS, Graham RA. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer. J Surg Res. 2014;192(2):235–41.

    Article  CAS  PubMed  Google Scholar 

  77. Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol. 2004;11(3):322–7.

    Article  PubMed  Google Scholar 

  78. Spaner DE, Miller RL, Mena J, Grossman L, Sorrenti V, Shi Y. Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the toll-like receptor-7/8 agonist, imiquimod. Leuk Lymphoma. 2005;46(6):935–9.

    Article  PubMed  Google Scholar 

  79. Steinmann A, Funk JO, Schuler G, von den Driesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol. 2000;43(3):555–6.

    CAS  PubMed  Google Scholar 

  80. Asakura M, Miura H. Imiquimod 5% cream for the treatment of nasal lesion of metastatic renal cell carcinoma. Dermatol Ther. 2011;24(3):375–7.

    Article  PubMed  Google Scholar 

  81. Henriques L, Palumbo M, Guay MP, Bahoric B, Basik M, Kavan P, Batist G. Imiquimod in the treatment of breast cancer skin metastasis. J Clin Oncol. 2014;32(8):e22–5.

    Article  PubMed  Google Scholar 

  82. Adams S, Kozhaya L, Martiniuk F, Meng TC, Chiriboga L, Liebes L, Hochman T, Shuman N, Axelrod D, Speyer J, Novik Y, Tiersten A, Goldberg JD, Formenti SC, Bhardwaj N, Unutmaz D, Demaria S. Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res. 2012;18(24):6748–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Salazar LG, Lu H, Reichow JL, Childs JS, Coveler AL, Higgins DM, Waisman J, Allison KH, Dang Y, Disis ML. Topical imiquimod plus nab-paclitaxel for breast cancer cutaneous metastases: a phase 2 clinical trial. JAMA Oncol. 2017;3(7):969–73.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Florin V, Desmedt E, Vercambre-Darras S, Mortier L. Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil. Investig New Drugs. 2012;30(4):1641–5.

    Article  CAS  Google Scholar 

  85. Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, Mansi J. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol. 2001;19(21):4150–9.

    Article  CAS  PubMed  Google Scholar 

  86. Goto H, Omodaka T, Yanagisawa H, Yoshikawa S, Yoshida Y, Yamamoto O, Kiyohara Y. Palliative surgical treatment for cutaneous metastatic tumor is a valid option for improvement of quality of life. J Dermatol. 2016;43(1):95–8.

    Article  PubMed  Google Scholar 

  87. Dabiri G, Damstetter E, Phillips T. Choosing a wound dressing based on common wound characteristics. Adv Wound Care (New Rochelle). 2016;5(1):32–41.

    Article  Google Scholar 

  88. Powers JG, Higham C, Broussard K, Phillips TJ. Wound healing and treating wounds: chronic wound care and management. J Am Acad Dermatol. 2016;74(4):607–25; quiz 625–6.

    Article  PubMed  Google Scholar 

  89. Wound Care Shop. Accessed: October 12, 2018; Available from: https://www.woundcareshop.com.

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA

    Brooke E. Corbett

  2. Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Nina R. Blank & Alina Markova

  3. Department of Dermatology, Weill Cornell Medical College, New York, NY, USA

    Nina R. Blank

Authors
  1. Brooke E. Corbett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nina R. Blank
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alina Markova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alina Markova .

Editor information

Editors and Affiliations

  1. Division of Dermatology, Department of Medicine, Women’s College Hospital, University of Toronto, Toronto, ON, Canada

    Afsaneh Alavi

  2. Department of Dermatology, University of San Francisco, San Francisco, CA, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Corbett, B.E., Blank, N.R., Markova, A. (2020). Comprehensive Wound Care for Malignant Wounds. In: Alavi, A., Maibach, H. (eds) Local Wound Care for Dermatologists. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-28872-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28872-3_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28871-6

  • Online ISBN: 978-3-030-28872-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation